- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Bemcentinib; pembrolizumab
Total 2293 results
-
Hackensack Meridian HealthCompletedMultiple MyelomaUnited States
-
University of LeedsKaryopharm Therapeutics Inc; Myeloma UKWithdrawnMyeloma MultipleUnited Kingdom
-
Yousef ZakhariaUniversity of IowaRecruitingClear Cell Renal Cell Carcinoma | Clear Cell Renal Cell Carcinoma MetastaticUnited States
-
Merck Sharp & Dohme LLCRecruitingCarcinoma, Hepatocellular | Colorectal Neoplasms | Esophageal Neoplasms | Endometrial Neoplasms | Pancreatic Ductal Adenocarcinoma | Biliary Tract NeoplasmsIsrael, United States, Australia, Belgium, Chile, France, Korea, Republic of, Netherlands, Spain, New Zealand
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCRecruitingPrimary Central Nervous System Lymphoma | Relapsed Cancer | Refractory Cancer | Recurrent CancerUnited States
-
OncoC4, Inc.National Cancer Institute (NCI)RecruitingCervical Cancer | Small Cell Lung Cancer | Adenoid Cystic Carcinoma | Metastatic Renal Cell Carcinoma | Metastatic Colorectal Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Metastatic Melanoma | Pancreas Cancer | Metastatic... and other conditionsUnited States, Australia
-
Janssen Research & Development, LLCActive, not recruitingUrothelial CancerKorea, Republic of, United States, Italy, Spain, Japan, United Kingdom, Belgium, Israel, China, Austria, France, Canada, Taiwan, Turkey, Germany, Russian Federation, Bulgaria, Poland, Greece, Brazil, Netherlands, Australia, Argentina, Mexic... and more
-
H. Lee Moffitt Cancer Center and Research InstituteMerck Sharp & Dohme LLCCompletedMalignant GliomaUnited States
-
Hackensack Meridian HealthCompletedMultiple MyelomaUnited States
-
Oncovir, Inc.National Cancer Institute (NCI); University of Missouri-Columbia; Icahn School... and other collaboratorsCompletedMelanoma | Sarcoma | Head and Neck Cancer | Non-Melanoma Skin CancersUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
IsalaRecruitingOncology | Infusion ReactionNetherlands
-
Niels JunkerKarolinska University Hospital; Oslo University Hospital; Aarhus University HospitalRecruitingSoft Tissue Sarcoma Adult | Angiosarcoma | Undifferentiated Pleomorphic SarcomaNorway, Sweden, Denmark
-
Daiichi SankyoMerck Sharp & Dohme LLC; AstraZenecaRecruitingMetastatic Non Small Cell Lung CancerBelgium, Australia, United States, Korea, Republic of, Spain, China, France, Germany, Thailand, Brazil, Japan, Hong Kong, Greece, Switzerland, Netherlands, Romania, Hungary, Italy, Chile, Taiwan, Austria, Poland, Canada, Argentina, Turkey
-
Haider MahdiMerck Sharp & Dohme LLC; ALX OncologyRecruiting
-
Tvardi Therapeutics, IncorporatedRecruitingHepatocellular CarcinomaUnited States
-
Fudan UniversityMerck Sharp & Dohme LLCRecruitingTriple Negative Breast CancerChina
-
Medicenna Therapeutics, Inc.Merck Sharp & Dohme LLCRecruitingClear Cell Renal Cell Carcinoma | Cervical Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Solid Tumor | Squamous Cell Carcinoma of Head and Neck | Bladder Cancer | Skin Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Primary Peritoneal Cancer | Endometrial Carcinoma and other conditionsUnited States, Australia, Korea, Republic of, Canada
-
Bryan Schneider, MDPfizer; Genentech, Inc.; Indiana University; Foundation Medicine; Vera Bradley Foundation...RecruitingBreast Cancer | Triple Negative Breast CancerUnited States
-
Cardiff UniversityRecruitingAnal Cancer Stage III A | Anal Cancer Stage III BUnited Kingdom, Norway
-
Icahn School of Medicine at Mount SinaiMerck Sharp & Dohme LLC; Celldex TherapeuticsRecruitingNon-Hodgkin's Lymphoma | Metastatic Breast Cancer | Head and Neck Squamous Cell CarcinomaUnited States
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Canada, Belgium, China, Denmark, Spain, Thailand, United Kingdom, Taiwan, Brazil, Germany, Mexico, Italy, Switzerland, Hong Kong, Japan, France, Turkey, New Zealand, Poland
-
AmgenCompletedSquamous-Cell Non-Small-Cell Lung CancerFrance, Belgium, Spain, United States, Taiwan, Korea, Republic of, Japan, Poland
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingMetastatic Non-Small Cell Lung CancerRussian Federation, Australia, United States, Argentina, Canada, Colombia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Portugal, Puerto Rico, Spain, United Kingdom
-
Belén Retamal-ValdesActive, not recruiting
-
Merck Sharp & Dohme LLCCompleted
-
Hackensack Meridian HealthMerck Sharp & Dohme LLCWithdrawnMultiple Myeloma, RefractoryUnited States
-
University of California, San FranciscoTerminatedMultiple Myeloma | Patient ParticipationUnited States
-
Merck Sharp & Dohme LLCRecruitingUterine Cervical Neoplasms | Stomach Neoplasms | Urinary Bladder Neoplasms | Hepatocellular Carcinoma | Esophageal Neoplasms | Ovarian Neoplasms | Endometrial Neoplasms | Squamous Cell Carcinoma of Head and Neck | Cholangiocarcinoma | Triple Negative Breast Neoplasms | Gallbladder NeoplasmsUnited States, Chile, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Spain, Taiwan, Turkey, Canada
-
Merck Sharp & Dohme LLCCompleted
-
University of Alabama at BirminghamNot yet recruiting
-
Dartmouth-Hitchcock Medical CenterNot yet recruitingTriple Negative Breast Cancer | Residual Disease
-
Mirati Therapeutics Inc.RecruitingMetastatic Lung Cancer | Advanced NSCLCUnited States, Spain, France, Hungary, Italy, Greece, Poland, Brazil, Chile, Georgia, Malaysia, Serbia, Switzerland, Thailand
-
Marina GarassinoRecruitingAdvanced LKB1-inactive Lung AdenocarcinomaItaly
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | Squamous Non Small Cell Lung Cancer | Nonsquamous Non Small Cell Lung CancerPhilippines, Thailand, France, Korea, Republic of, Hong Kong, United States, Turkey, Malaysia, Taiwan, Brazil, Serbia, Greece, Slovakia, Peru, South Africa, Mexico, Vietnam, Bangladesh
-
Merck Sharp & Dohme LLCActive, not recruitingTriple Negative Breast NeoplasmsColombia, United States, Canada, Chile, France, Germany, Hungary, Ireland, Japan, Korea, Republic of, Poland, Spain, Taiwan, Ukraine, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingNon-small Cell Lung CancerUnited States, Argentina, Australia, Belgium, Brazil, Canada, China, Estonia, France, Germany, Ireland, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Malaysia, Poland, Romania, Russian Federation, South Africa, Spain, Taiwan, U... and more
-
Novartis PharmaceuticalsWithdrawn
-
Vanderbilt-Ingram Cancer CenterMerck Sharp & Dohme LLCRecruitingLimited Stage Lung Small Cell Carcinoma | Stage III Lung Cancer | Stage I Lung Cancer | Stage II Lung CancerUnited States
-
Trishula Therapeutics, Inc.CompletedLymphoma | Solid TumorUnited States
-
M.D. Anderson Cancer CenterZentalis PharmaceuticalsWithdrawnBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | TumorsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Nantes University HospitalCompleted
-
Merck Sharp & Dohme LLCRecruitingTriple-Negative Breast CancerUnited States
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)China, Australia, United States, Turkey, Chile, Taiwan, Denmark, France, Spain, Argentina, Italy, Netherlands, Thailand, Korea, Republic of
-
Gilead SciencesAlliance Foundation Trials, LLC.; NSABP Foundation IncRecruitingTriple Negative Breast CancerUnited States
-
Massachusetts General HospitalMassachusetts Institute of TechnologyRecruiting
-
SanofiRecruitingCancer | NeoplasmUnited States, Israel